Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 13, 2021

SELL
$25.68 - $38.61 $235,485 - $354,053
-9,170 Closed
0 $0
Q2 2021

Jul 15, 2021

BUY
$25.96 - $33.44 $238,053 - $306,644
9,170 New
9,170 $259,000
Q1 2021

Apr 21, 2021

SELL
$27.56 - $40.37 $674,668 - $988,257
-24,480 Closed
0 $0
Q4 2020

Jan 20, 2021

BUY
$31.74 - $51.34 $776,995 - $1.26 Million
24,480 New
24,480 $885,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.